Viewing data from:

NORTRIPTYLINE HYDROCHLORIDE

ANDA

NORTRIPTYLINE HYDROCHLORIDE | A073556 | DR REDDYS LABORATORIES SA

4 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 7 NDCs

Highest NADAC/Unit

$0.2585

per ea

Lowest NADAC/Unit

$0.1172

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
75907007201NORTRIPTYLINE HCL 75 MG CAP	$0.2585	EA	Generic	—	2026-06-17
75907007105NORTRIPTYLINE HCL 50 MG CAP	$0.2034	EA	Generic	—	2026-06-17
75907007101NORTRIPTYLINE HCL 50 MG CAP	$0.2034	EA	Generic	—	2026-06-17
75907007005NORTRIPTYLINE HCL 25 MG CAP	$0.1608	EA	Generic	—	2026-06-17
75907007001NORTRIPTYLINE HCL 25 MG CAP	$0.1608	EA	Generic	—	2026-06-17
75907006901NORTRIPTYLINE HCL 10 MG CAP	$0.1172	EA	Generic	—	2026-06-17
75907006905NORTRIPTYLINE HCL 10 MG CAP	$0.1172	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs2 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SIGMA ALDRICH IRELAND LTDNORTRIPTYLINE HYDROCHLORIDE

DMF 74141988

VASUDHA PHARMA CHEM LTDNORTRIPTYLINE HYDROCHLORIDE USP

DMF 319742017

RL FINE CHEM PVT LTDNORTRIPTYLINE HYDROCHLORIDE

DMF 332272018

DSM PHARMA CHEMICALS SOUTH HAVEN INCInactiveNORTRIPTYLINE HYDROCHLORIDE

DMF 83881990

ZYDUS LIFESCIENCES LTDInactiveNORTRIPTYLINE HYDROCHLORIDE USP

DMF 213302008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#001 — EQ 75MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Mar 30, 1992

No patent or exclusivity listings for this strength.

#002 — EQ 10MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 30, 1992

#003 — EQ 25MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 30, 1992

#004 — EQ 50MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 30, 1992